Lilly's Foundayo Shows Cardiovascular Safety With A1c and Weight Loss Benefits
Eli Lilly and Company's Foundayo drug demonstrated cardiovascular safety alongside sustained A1c reduction and weight loss in its studies.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.